MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-24-0003897
U.S. Labco Private Limited
U.S. Labco Private Limited - pharma in Jabalpur, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.89 Cr
▼ 14% YoY
Net profit · FY 2025
₹32.47 Lakh
Net margin 3.7%
EBITDA · FY 2025
₹52.11 Lakh
EBITDA margin 5.9%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹1.06 Cr
Secured borrowings
Company age
21 yrs
Est. 2005
Directors on board
4
As per MCA filings
About U.S. Labco Private Limited
Data last updated:
U.S. Labco Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 April 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U02423MP2005PTC017523. Its GSTIN is 23AAACU8693E1Z7 (Madhya Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Poonam Gandhi and Ashutosh Gandhi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 15 Dawa Bazar Civic Centre, Jabalpur, Madhya Pradesh, India – 482002.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.89 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹32.47 Lakh (net margin 3.7%) and EBITDA of ₹52.11 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹1.06 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
U.S. Labco Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-24-0003897). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U02423MP2005PTC017523
Registration Number 017523
Incorporation Date 15 April 2005
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-24-0003897
Recognitions & Rankings of U.S. Labco
Contact details
U.S. Labco Private Limited's registered office is in Jabalpur, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 15 Dawa Bazar Civic Centre, Jabalpur, Madhya Pradesh, India – 482002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of U.S. Labco Private Limited, buy the company report.
Comprehensive company report
U.S. Labco Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of U.S. Labco is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of U.S. Labco Private Limited, buy the company report.
Financials of U.S. Labco Private Limited
FY 2025 filings availableU.S. Labco Private Limited reported revenue of ₹8.89 Cr (down 14% YoY) for FY 2025.
Revenue · FY 2025
₹8.89 Cr ▼ 14%
Net profit · FY 2025
₹32.47 Lakh margin 3.7%
EBITDA · FY 2025
₹52.11 Lakh margin 5.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 14%
3 years · compounded
▼ 20%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 12%
5 years · compounded
▲ 20%
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of U.S. Labco Private Limited, buy the company report.
Board of directors of U.S. Labco Private Limited
U.S. Labco has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Gandhi | Director | 15 Apr 2005 | 21 Years 6 Months | Current |
| Ashutosh Gandhi | Director | 15 Apr 2005 | 21 Years 6 Months | Current |
| Urmila Gandhi | Director | 15 Apr 2005 | 21 Years 6 Months | Current |
| Ramesh Chand Gandhi | Director | 15 Apr 2005 | 21 Years 6 Months | Current |
Peer comparison
U.S. Labco Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kanhangad Links Private Limited | ₹8.91 Cr (FY 2025) | 9.0% | Kasaragod, Kerala, India | |||
| Triveni Meditech Private Limited | ₹8.91 Cr (FY 2019) | -9.0% | Jaipur, Rajasthan, India | |||
| Chhattisgarh C and F Agency Private Limited | ₹8.9 Cr (FY 2025) | 71.0% | Raipur, Chhattisgarh, India | |||
| U.S. Labco Private Limitedthis company | ₹8.89 Cr (FY 2025) | ₹32.47 Lakh | 3.7% | -14.0% | Jabalpur, Madhya Pradesh, India | |
| Agm Biotech Private Limited | ₹8.87 Cr (FY 2025) | 2.0% | Rudrapur, Uttarakhand, India | |||
| Royal Medical Private Limited | ₹8.84 Cr (FY 2024) | -47.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of U.S. Labco Private Limited, buy the company report.
Auditor
U.S. Labco Private Limited is audited by R KHANDELWAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R KHANDELWAL & ASSOCIATES | FY 2021 | 006136C |
Shareholding
The shareholding of U.S. Labco Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of U.S. Labco Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.06 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jul 2008 | 10113034 | State Bank of India | ₹1.06 Cr | Open |
To see the full charge records of U.S. Labco Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
U.S. Labco Private Limited has 3 court cases on record: 3 filed by U.S. Labco. All cases are pending.
Total cases
3
Filed by the company
3
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jabalpur, Madhya Pradesh | Court case (SC NIA) | Filed by the company against an individual | Pending |
| District court, Jabalpur, Madhya Pradesh | Court case (UN CR) | Filed by the company against an individual | Pending |
To see the full case history of U.S. Labco Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for U.S. Labco Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
U.S. Labco has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACU8693E1Z7 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of U.S. Labco Private Limited, buy the company report.
Recent activity
U.S. Labco Private Limited has 4 board changes on record since 2005: 4 appointments. The latest: Ashutosh Gandhi was appointed as Director on 15 Apr 2005.
AGM
U.S. Labco Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
U.S. Labco Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with State Bank Of India of Rs. 105.90 Lakh registered on 24 Jul 2008 with Charge ID 10113034 was modified on 28 Dec 2016.
Charges
A charge with State Bank Of India amounted to Rs. 105.90 Lakh with Charge ID 10113034 was registered on 24 Jul 2008.
Appointed
Ashutosh Gandhi was appointed as Director.
Appointed
Poonam Gandhi was appointed as Director.
Appointed
Ramesh Chand Gandhi was appointed as Director.
Appointed
Urmila Gandhi was appointed as Director.
Incorporation
15 Apr 2005
U.S. Labco Private Limited was registered on 15 Apr 2005 with Roc Gwalior & aged 21 years 6 months as per MCA records.
Frequently asked questions
U.S. Labco is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 April 2005 (21+ years old) and is registered under CIN U02423MP2005PTC017523.
U.S. Labco has 4 current directors:
- Poonam Gandhi - Director
- Ashutosh Gandhi - Director
- Urmila Gandhi - Director
- Ramesh Chand Gandhi - Director
The latest financial statements of U.S. Labco on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of U.S. Labco is 23AAACU8693E1Z7, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of U.S. Labco is U02423MP2005PTC017523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
U.S. Labco has 3 court cases on record: 3 filed by the company. 3 are pending.
U.S. Labco was incorporated on 15 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of U.S. Labco by revenue are Kanhangad Links Private Limited, Triveni Meditech Private Limited, Chhattisgarh C and F Agency Private Limited, Agm Biotech Private Limited, Royal Medical Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ashutosh Gandhi was appointed as Director on 15 Apr 2005. Poonam Gandhi was appointed as Director on 15 Apr 2005. Ramesh Chand Gandhi was appointed as Director on 15 Apr 2005. U.S. Labco has 4 board changes on record in total.
Yes, U.S. Labco is registered as a small enterprise under Udyam registration (number: UDYAM-MP-24-0003897).
The registered office of U.S. Labco is at Shop No. 15 Dawa Bazar Civic Centre, Jabalpur, Madhya Pradesh, India – 482002.